Oncology Information System Market by Product and Service, Application, End User (Hospitals & diagnostic imaging centers, Ablation & Cancer Care Centers, Government Institutions and Research Facilities) - Global Forecast to 2027
Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient. Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions to curtail the increasing cost of care and growing cases of cancer is expected to witness strong growth during forecasted period. For instance, as per National Cancer Institute, by 2040, the new cancer cases will rise by 29.5 million and the number of cancer related deaths to 16.4 million per year. Moreover, development of wide range of novel technologies will bring significant opportunities for oncology information system market during the forecast period.
“The Software segment held the largest share during the forecast period.”
Software segment accounted for 83.6% of the oncology information system market for product and services in 2021. Software is a non-tangible component used to run a system or perform primary tasks, which include maintaining patient records and performing treatment planning in any healthcare organization or hospital. It is an integral part of the HCIT market and works as an interface between the database and end users. Healthcare organizations are moving from on-premise models to web- and cloud-based models, which fuels the growth of this segment during the forecast period.
“Radiation oncology segment held the largest share during the forecast period.”
In 2021, the radiation oncology segment accounted for 53.8% of the oncology information system market for application. Radiation oncology specializes in treating cancer with radiation—delivering a high radiation dose directly to the tumor to kill cancer cells with minimum exposure to healthy tissue that surrounds the tumor. This limits complications, side-effects, and secondary effects to healthy tissues, which is driving advancements in radiation oncology. Some of the novel radiation oncology therapies that are widely used include external beam radiation therapy (EBRT), internal beam radiation therapy (IBRT), intraoperative radiation therapy (IORT), and brachytherapy. Integration of radiotherapy system with OIS enables clinicians to accelerate radiation dose calculation speed and improve the overall treatment planning efficiency.
“The hospitals and diagnostic imaging centers segment held the largest share during the forecast period.”
In 2021, hospitals and diagnostic imaging centers accounted for 64.5% of the oncology information system market. Hospitals are the largest end-users of oncology information systems owing to the significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems, increasing number of cancer care procedures, and the growing adoption of oncology treatment care. Growing burden of various types of cancers, and increasing number of diagnostic procedures performed globally are some of the factors driving the growth for diagnostic imagaing centers in oncology information system market.
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the increasing investment for advancement of healthcare IT infrastructure, and increasing government support for implementation of healthcare IT solutions in healthcare settings. According to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the oncology information system market.
Research Coverage:
This report describes and studies the global oncology information system market based product and services, application, end user and regional level. It provides detailed information regarding the major factors influencing the growth of this market. The report includes an in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments, and MNM overview.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall oncology information system market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
This report provides insights on:
“The Software segment held the largest share during the forecast period.”
Software segment accounted for 83.6% of the oncology information system market for product and services in 2021. Software is a non-tangible component used to run a system or perform primary tasks, which include maintaining patient records and performing treatment planning in any healthcare organization or hospital. It is an integral part of the HCIT market and works as an interface between the database and end users. Healthcare organizations are moving from on-premise models to web- and cloud-based models, which fuels the growth of this segment during the forecast period.
“Radiation oncology segment held the largest share during the forecast period.”
In 2021, the radiation oncology segment accounted for 53.8% of the oncology information system market for application. Radiation oncology specializes in treating cancer with radiation—delivering a high radiation dose directly to the tumor to kill cancer cells with minimum exposure to healthy tissue that surrounds the tumor. This limits complications, side-effects, and secondary effects to healthy tissues, which is driving advancements in radiation oncology. Some of the novel radiation oncology therapies that are widely used include external beam radiation therapy (EBRT), internal beam radiation therapy (IBRT), intraoperative radiation therapy (IORT), and brachytherapy. Integration of radiotherapy system with OIS enables clinicians to accelerate radiation dose calculation speed and improve the overall treatment planning efficiency.
“The hospitals and diagnostic imaging centers segment held the largest share during the forecast period.”
In 2021, hospitals and diagnostic imaging centers accounted for 64.5% of the oncology information system market. Hospitals are the largest end-users of oncology information systems owing to the significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems, increasing number of cancer care procedures, and the growing adoption of oncology treatment care. Growing burden of various types of cancers, and increasing number of diagnostic procedures performed globally are some of the factors driving the growth for diagnostic imagaing centers in oncology information system market.
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the increasing investment for advancement of healthcare IT infrastructure, and increasing government support for implementation of healthcare IT solutions in healthcare settings. According to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the oncology information system market.
- By Company Type: Tier 1: 46%, Tier 2: 33%, and Tier 3: 21%
- By Designation: C-level Executives: 43%, Directors: 35%, and Others: 22%
- By Region: North America: 30%, Europe: 35%, APAC: 24%, Latin America: 14% and Middle East & Africa: 4%
Research Coverage:
This report describes and studies the global oncology information system market based product and services, application, end user and regional level. It provides detailed information regarding the major factors influencing the growth of this market. The report includes an in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments, and MNM overview.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall oncology information system market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
This report provides insights on:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the oncology information system market. The report analyzes this market by product and services, application, end user and region.
- Market Development: Comprehensive information on the lucrative emerging markets, by product and services, application, end user and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the oncology information system market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the oncology information system market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 SECONDARY RESEARCH
2.1.3 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
2.1.3.2 Breakdown of primary sources
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 PRIMARY SOURCES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 10 ONCOLOGY INFORMATION SYSTEMS MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022–2027)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 20 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 21 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW
FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022–2027)
FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY APPLICATION AND COUNTRY (2021)
FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.4 ONCOLOGY INFORMATION SYSTEMS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Need to curtail oncology care costs
FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015–2021 (USD BILLION)
5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019)
5.2.1.3 Increasing incidence and prevalence of cancer
TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016–2020
5.2.1.4 Favorable government mandates and support for oncology information systems
5.2.1.5 Potential benefits of and technological advancements in oncology information systems
5.2.2 RESTRAINTS
5.2.2.1 Interoperability issues
5.2.2.2 Dearth of skilled IT professionals in healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare IT Industry
5.2.3.2 Integration of EMR with treatment planning systems
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding data privacy
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
6.2.1 ARTIFICIAL INTELLIGENCE
6.2.2 MACHINE LEARNING
6.2.3 INTERNET OF THINGS
6.2.4 BLOCKCHAIN
6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEMS MARKET
FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM
6.5 REGULATORY ANALYSIS
6.5.1 NORTH AMERICA
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
6.5.4 MIDDLE EAST & AFRICA
6.5.5 LATIN AMERICA
6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.7 PORTER’S FIVE FORCES ANALYSIS
FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEMS MARKET
TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7.1 THREAT OF NEW ENTRANTS
6.7.2 THREAT OF SUBSTITUTES
6.7.3 BARGAINING POWER OF SUPPLIERS
6.7.4 BARGAINING POWER OF BUYERS
6.7.5 INTENSITY OF COMPETITIVE RIVALRY
6.8 KEY STAKEHOLDERS & BUYING CRITERIA
6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
6.9 KEY BUYING CRITERIA BY END USERS
FIGURE 34 BUYING CRITERIA OF END USERS
TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6.10 PATENT ANALYSIS
6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS
FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018–2022
6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS
FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018–2022
6.11 KEY CONFERENCES & EVENTS IN 2022-2023
TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEMS MARKET
7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 SOFTWARE
TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 PATIENT INFORMATION SYSTEMS
TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.1 Oncology electronic medical records
7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries
TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS
TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.2 Laboratory information systems
7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS
TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.3 Radiology information systems
7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders
TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS
TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.4 Chemotherapy information systems
7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types
TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS
TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 TREATMENT PLANNING SYSTEMS
TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.1 Radiotherapy treatment planning systems
7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors
TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS
TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.2 Clinical decision support systems
7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS
TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.3 Brachytherapy treatment planning systems
7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems
TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS
TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.1 Population health management solutions
7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers
TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS
TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 Clinical integration solutions
7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth
TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS
TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions
7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions
TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS
TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.4 Advanced visualization & image analysis solutions
7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth
TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.5 Radiation dose management solutions
7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management
TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 PROFESSIONAL SERVICES
TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 IMPLEMENTATION SERVICES
7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services
TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES
TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 POST-SALE & MAINTENANCE SERVICES
7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services
TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES
TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 CONSULTING & OPTIMIZATION SERVICES
7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions
TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES
TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 52 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 RADIATION ONCOLOGY
8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH
TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET
TABLE 55 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 MEDICAL ONCOLOGY
8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET
FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012–2018
TABLE 57 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 SURGICAL ONCOLOGY
8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH
TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET
TABLE 59 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS
9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021)
TABLE 62 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 ABLATION & CANCER CARE CENTERS
9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH
TABLE 63 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 GOVERNMENT INSTITUTES
9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
TABLE 64 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 RESEARCH FACILITIES
9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH
TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 38 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 66 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth
FIGURE 40 US: HOSPITAL EHR ADOPTION (2010–2018)
TABLE 76 US: KEY MACROINDICATORS
TABLE 77 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada
FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS, 2013–2018
TABLE 83 CANADA: KEY MACROINDICATORS
TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030
TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany
TABLE 99 GERMANY: KEY MACROINDICATORS
TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs
TABLE 106 UK: KEY MACROINDICATORS
TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Growing reforms in digital health will support market growth
TABLE 113 FRANCE: KEY MACROINDICATORS
TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing government initiatives and reforms to drive market growth
TABLE 120 ITALY: KEY MACROINDICATORS
TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems
TABLE 127 SPAIN: KEY MACROINDICATORS
TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan dominates Asia Pacific oncology information systems market
TABLE 149 JAPAN: KEY MACROINDICATORS
TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strong government support in China to propel market growth
TABLE 156 CHINA: KEY MACROINDICATORS
TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India
TABLE 163 INDIA: KEY MACROINDICATORS
TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth
TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth
TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Modernization of healthcare infrastructure to drive market growth
TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth
TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
TABLE 215 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY DEVELOPMENTS BY LEADING PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET, JANUARY 2018–APRIL 2022
11.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 44 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
TABLE 223 ONCOLOGY INFORMATION SYSTEMS MARKET: DEGREE OF COMPETITION
11.5 MARKET RANKING ANALYSIS
FIGURE 45 RANK OF COMPANIES IN GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET (2021)
11.6 COMPETITIVE LEADERSHIP MAPPING
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 46 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 47 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
11.8 COMPETITIVE BENCHMARKING
TABLE 224 ONCOLOGY INFORMATION SYSTEMS MARKET: SUPPORTING DATA OF KEY START-UPS/SMES
11.9 COMPETITIVE BENCHMARKING FOR STARTUPS/SMES
TABLE 225 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
11.10 ONCOLOGY INFORMATION SYSTEMS MARKET: R&D EXPENDITURE
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET (2020 VS. 2021)
11.11 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
FIGURE 49 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET
11.12 COMPANY REGIONAL FOOTPRINT
TABLE 226 COMPANY REGIONAL FOOTPRINT
TABLE 227 COMPANY SOFTWARE FOOTPRINT
TABLE 228 COMPANY SERVICE FOOTPRINT
TABLE 229 COMPANY APPLICATION FOOTPRINT
11.13 COMPETITIVE SITUATION AND TRENDS
11.13.1 PRODUCT LAUNCHES
TABLE 230 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY PRODUCT LAUNCHES
11.13.2 DEALS
TABLE 231 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY DEALS
11.13.3 OTHER DEVELOPMENTS
TABLE 232 ONCOLOGY INFORMATION SYSTEMS MARKET: OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 233 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
12.1.2 SIEMENS HEALTHINEERS
TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
12.1.3 ELEKTA
TABLE 235 ELEKTA: BUSINESS OVERVIEW
FIGURE 52 ELEKTA: COMPANY SNAPSHOT (2021)
12.1.4 GE HEALTHCARE
TABLE 236 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.5 MCKESSON CORPORATION
TABLE 237 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 54 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 CERNER CORPORATION
TABLE 238 CERNER CORPORATION: BUSINESS OVERVIEW
FIGURE 55 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
12.2.2 ACCURAY INCORPORATED
TABLE 239 ACCURAY INCORPORATED: BUSINESS OVERVIEW
FIGURE 56 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021)
12.2.3 ALLSCRIPTS HEALTHCARE, LLC
TABLE 240 ALLSCRIPTS HEALTHCARE, LLC.: BUSINESS OVERVIEW
FIGURE 57 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
12.2.4 IBM
TABLE 241 IBM: BUSINESS OVERVIEW
FIGURE 58 IBM: COMPANY SNAPSHOT (2021)
12.2.5 F. HOFFMANN-LA ROCHE AG
TABLE 242 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
FIGURE 59 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
12.2.6 EPIC SYSTEMS CORPORATION
TABLE 243 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
12.2.7 RAYSEARCH LABORATORIES
TABLE 244 RAYSEARCH LABORATORIES: BUSINESS OVERVIEW
FIGURE 60 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2021)
12.2.8 CUREMD HEALTHCARE
TABLE 245 CUREMD HEALTHCARE: BUSINESS OVERVIEW
12.2.9 BOGARDUS MEDICAL SYSTEMS, INC.
TABLE 246 BOGARDUS MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
12.2.10 OPTUM (UNITEDHEALTH GROUP)
TABLE 247 OPTUM: BUSINESS OVERVIEW
FIGURE 61 OPTUM: COMPANY SNAPSHOT (2021)
12.2.11 MICA INFORMATION SYSTEMS, INC.
TABLE 248 MICA INFORMATION SYSTEMS, INC.: BUSINESS OVERVIEW
12.2.12 ADVANCED DATA SYSTEMS
TABLE 249 ADVANCED DATA SYSTEMS: BUSINESS OVERVIEW
12.2.13 ENDOSOFT LLC
TABLE 250 ENDOSOFT LLC: BUSINESS OVERVIEW
12.2.14 ALTAI ONCOLOGY, LLC
TABLE 251 ALTAI ONCOLOGY, LLC: BUSINESS OVERVIEW
12.2.15 MIM SOFTWARE INC.
TABLE 252 MIM SOFTWARE INC.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 SECONDARY RESEARCH
2.1.3 PRIMARY RESEARCH
FIGURE 3 PRIMARY SOURCES
2.1.3.1 Key data from primary sources
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS
2.1.3.2 Breakdown of primary sources
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 PRIMARY SOURCES
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 10 ONCOLOGY INFORMATION SYSTEMS MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022–2027)
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 13 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET
3 EXECUTIVE SUMMARY
FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 20 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 21 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET
4 PREMIUM INSIGHTS
4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW
FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022–2027)
FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY APPLICATION AND COUNTRY (2021)
FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.4 ONCOLOGY INFORMATION SYSTEMS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION)
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Need to curtail oncology care costs
FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015–2021 (USD BILLION)
5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019)
5.2.1.3 Increasing incidence and prevalence of cancer
TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016–2020
5.2.1.4 Favorable government mandates and support for oncology information systems
5.2.1.5 Potential benefits of and technological advancements in oncology information systems
5.2.2 RESTRAINTS
5.2.2.1 Interoperability issues
5.2.2.2 Dearth of skilled IT professionals in healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare IT Industry
5.2.3.2 Integration of EMR with treatment planning systems
5.2.4 CHALLENGES
5.2.4.1 Concerns regarding data privacy
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
6.2.1 ARTIFICIAL INTELLIGENCE
6.2.2 MACHINE LEARNING
6.2.3 INTERNET OF THINGS
6.2.4 BLOCKCHAIN
6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS
6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEMS MARKET
FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM
6.5 REGULATORY ANALYSIS
6.5.1 NORTH AMERICA
6.5.2 EUROPE
6.5.3 ASIA PACIFIC
6.5.4 MIDDLE EAST & AFRICA
6.5.5 LATIN AMERICA
6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.7 PORTER’S FIVE FORCES ANALYSIS
FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEMS MARKET
TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS
6.7.1 THREAT OF NEW ENTRANTS
6.7.2 THREAT OF SUBSTITUTES
6.7.3 BARGAINING POWER OF SUPPLIERS
6.7.4 BARGAINING POWER OF BUYERS
6.7.5 INTENSITY OF COMPETITIVE RIVALRY
6.8 KEY STAKEHOLDERS & BUYING CRITERIA
6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
6.9 KEY BUYING CRITERIA BY END USERS
FIGURE 34 BUYING CRITERIA OF END USERS
TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6.10 PATENT ANALYSIS
6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS
FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018–2022
6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS
FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018–2022
6.11 KEY CONFERENCES & EVENTS IN 2022-2023
TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEMS MARKET
7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
7.2 SOFTWARE
TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 PATIENT INFORMATION SYSTEMS
TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.1 Oncology electronic medical records
7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries
TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS
TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.2 Laboratory information systems
7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS
TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.3 Radiology information systems
7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders
TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS
TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.4 Chemotherapy information systems
7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types
TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS
TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 TREATMENT PLANNING SYSTEMS
TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.1 Radiotherapy treatment planning systems
7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors
TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS
TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.2 Clinical decision support systems
7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS
TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.3 Brachytherapy treatment planning systems
7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems
TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS
TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.1 Population health management solutions
7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers
TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS
TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 Clinical integration solutions
7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth
TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS
TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions
7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions
TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS
TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.4 Advanced visualization & image analysis solutions
7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth
TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.5 Radiation dose management solutions
7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management
TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 PROFESSIONAL SERVICES
TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 IMPLEMENTATION SERVICES
7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services
TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES
TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 POST-SALE & MAINTENANCE SERVICES
7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services
TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES
TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 CONSULTING & OPTIMIZATION SERVICES
7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions
TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES
TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 52 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 RADIATION ONCOLOGY
8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH
TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET
TABLE 55 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 MEDICAL ONCOLOGY
8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET
FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012–2018
TABLE 57 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 SURGICAL ONCOLOGY
8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH
TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET
TABLE 59 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS
9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021)
TABLE 62 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 ABLATION & CANCER CARE CENTERS
9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH
TABLE 63 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 GOVERNMENT INSTITUTES
9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
TABLE 64 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 RESEARCH FACILITIES
9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH
TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 38 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 66 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth
FIGURE 40 US: HOSPITAL EHR ADOPTION (2010–2018)
TABLE 76 US: KEY MACROINDICATORS
TABLE 77 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada
FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS, 2013–2018
TABLE 83 CANADA: KEY MACROINDICATORS
TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012–2030
TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany
TABLE 99 GERMANY: KEY MACROINDICATORS
TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs
TABLE 106 UK: KEY MACROINDICATORS
TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Growing reforms in digital health will support market growth
TABLE 113 FRANCE: KEY MACROINDICATORS
TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing government initiatives and reforms to drive market growth
TABLE 120 ITALY: KEY MACROINDICATORS
TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems
TABLE 127 SPAIN: KEY MACROINDICATORS
TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan dominates Asia Pacific oncology information systems market
TABLE 149 JAPAN: KEY MACROINDICATORS
TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Strong government support in China to propel market growth
TABLE 156 CHINA: KEY MACROINDICATORS
TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India
TABLE 163 INDIA: KEY MACROINDICATORS
TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth
TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth
TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Modernization of healthcare infrastructure to drive market growth
TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth
TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
TABLE 215 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY DEVELOPMENTS BY LEADING PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET, JANUARY 2018–APRIL 2022
11.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 44 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
TABLE 223 ONCOLOGY INFORMATION SYSTEMS MARKET: DEGREE OF COMPETITION
11.5 MARKET RANKING ANALYSIS
FIGURE 45 RANK OF COMPANIES IN GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET (2021)
11.6 COMPETITIVE LEADERSHIP MAPPING
11.6.1 STARS
11.6.2 EMERGING LEADERS
11.6.3 PERVASIVE PLAYERS
11.6.4 PARTICIPANTS
FIGURE 46 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
11.7.1 PROGRESSIVE COMPANIES
11.7.2 STARTING BLOCKS
11.7.3 RESPONSIVE COMPANIES
11.7.4 DYNAMIC COMPANIES
FIGURE 47 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
11.8 COMPETITIVE BENCHMARKING
TABLE 224 ONCOLOGY INFORMATION SYSTEMS MARKET: SUPPORTING DATA OF KEY START-UPS/SMES
11.9 COMPETITIVE BENCHMARKING FOR STARTUPS/SMES
TABLE 225 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
11.10 ONCOLOGY INFORMATION SYSTEMS MARKET: R&D EXPENDITURE
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET (2020 VS. 2021)
11.11 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
FIGURE 49 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET
11.12 COMPANY REGIONAL FOOTPRINT
TABLE 226 COMPANY REGIONAL FOOTPRINT
TABLE 227 COMPANY SOFTWARE FOOTPRINT
TABLE 228 COMPANY SERVICE FOOTPRINT
TABLE 229 COMPANY APPLICATION FOOTPRINT
11.13 COMPETITIVE SITUATION AND TRENDS
11.13.1 PRODUCT LAUNCHES
TABLE 230 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY PRODUCT LAUNCHES
11.13.2 DEALS
TABLE 231 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY DEALS
11.13.3 OTHER DEVELOPMENTS
TABLE 232 ONCOLOGY INFORMATION SYSTEMS MARKET: OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 KONINKLIJKE PHILIPS N.V.
TABLE 233 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
12.1.2 SIEMENS HEALTHINEERS
TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021)
12.1.3 ELEKTA
TABLE 235 ELEKTA: BUSINESS OVERVIEW
FIGURE 52 ELEKTA: COMPANY SNAPSHOT (2021)
12.1.4 GE HEALTHCARE
TABLE 236 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2021)
12.1.5 MCKESSON CORPORATION
TABLE 237 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 54 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
12.2 OTHER PLAYERS
12.2.1 CERNER CORPORATION
TABLE 238 CERNER CORPORATION: BUSINESS OVERVIEW
FIGURE 55 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
12.2.2 ACCURAY INCORPORATED
TABLE 239 ACCURAY INCORPORATED: BUSINESS OVERVIEW
FIGURE 56 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021)
12.2.3 ALLSCRIPTS HEALTHCARE, LLC
TABLE 240 ALLSCRIPTS HEALTHCARE, LLC.: BUSINESS OVERVIEW
FIGURE 57 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
12.2.4 IBM
TABLE 241 IBM: BUSINESS OVERVIEW
FIGURE 58 IBM: COMPANY SNAPSHOT (2021)
12.2.5 F. HOFFMANN-LA ROCHE AG
TABLE 242 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
FIGURE 59 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021)
12.2.6 EPIC SYSTEMS CORPORATION
TABLE 243 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
12.2.7 RAYSEARCH LABORATORIES
TABLE 244 RAYSEARCH LABORATORIES: BUSINESS OVERVIEW
FIGURE 60 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2021)
12.2.8 CUREMD HEALTHCARE
TABLE 245 CUREMD HEALTHCARE: BUSINESS OVERVIEW
12.2.9 BOGARDUS MEDICAL SYSTEMS, INC.
TABLE 246 BOGARDUS MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
12.2.10 OPTUM (UNITEDHEALTH GROUP)
TABLE 247 OPTUM: BUSINESS OVERVIEW
FIGURE 61 OPTUM: COMPANY SNAPSHOT (2021)
12.2.11 MICA INFORMATION SYSTEMS, INC.
TABLE 248 MICA INFORMATION SYSTEMS, INC.: BUSINESS OVERVIEW
12.2.12 ADVANCED DATA SYSTEMS
TABLE 249 ADVANCED DATA SYSTEMS: BUSINESS OVERVIEW
12.2.13 ENDOSOFT LLC
TABLE 250 ENDOSOFT LLC: BUSINESS OVERVIEW
12.2.14 ALTAI ONCOLOGY, LLC
TABLE 251 ALTAI ONCOLOGY, LLC: BUSINESS OVERVIEW
12.2.15 MIM SOFTWARE INC.
TABLE 252 MIM SOFTWARE INC.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
